Truist Securities Reiterates Buy Rating on Viking (VKTX) on Q1 Report, "We Like Risk/Reward Here"
Tweet Send to a Friend
Truist Securities analyst Joon Lee reiterated a Buy rating and $170.00 price target on Viking Therapeutic (NASDAQ: VKTX), following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
